# Transcat Inc. (TRNS) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Industrials / Specialty Business Services. Price $85.48, market value $800 million.

## Valuation
- **P/E (trailing): 237.4×** (5-yr avg 70.3×, 3-yr avg 80.1×). Transcat Inc. trades at 237.4× trailing earnings, well above its own five-year average of 70.3×: investors are paying up relative to the company's past. The Industrials median in the September 2026 study was 25.7×. Forward P/E is 39.4×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 2.3×**. Each dollar of revenue is priced at 2.3×.
- **Price / book: 2.7×**. The shares trade at 2.7× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: 2.4%** (5-yr avg 2.3%). Free cash flow equals 2.4% of the market value, in line with its five-year average of 2.3%.
- **Earnings yield: 0.4%**. The inverse of the P/E: 0.4% of the price is earned each year.

## Profitability
- **Net margin: 1.6%**. 1.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 1.8%**. 1.8% on shareholders' equity is weak; the business earns little on the capital its owners have in it.

## Growth
- **Revenue growth (1 yr): 19.2%** (3-yr 12.9%/yr, 5-yr 13.9%/yr). Revenue grew 19.2% over the last year, against 13.9% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): -63.7%** (3-yr -25.9%/yr, 5-yr -11.2%/yr). Earnings per share fell 63.7%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 37.4%/yr**. Free cash flow has compounded at 37.4% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.33**. Debt is 0.33 times equity: a conservative balance sheet.
- **Altman Z-score: 4.33**. A Z-score of 4.33 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Transcat Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 10.1%** (YTD 50.7%, 3-mo -2.6%). The shares are up 10.1% over twelve months including dividends.
- **From 52-week high: -14.5%** (70.2% above the low). Trading 15% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 42**. An RSI of 42 is neutral.
- **Beta (1 yr): 1.32** (volatility 47%). Beta of 1.32 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=TRNS · Page: https://foliofundamentals.com/stocks/trns

Not investment advice.